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t the neuromuscular junction, acetylcholinesterase
(AChE) is mainly present as asymmetric forms in
which tetramers of catalytic subunits are associated
to a speciﬁc collagen, collagen Q (ColQ). The accumulation
of the enzyme in the synaptic basal lamina strictly relies on
ColQ. This has been shown to be mediated by interaction
between ColQ and perlecan, which itself binds dystroglycan.
Here, using transfected mutants of ColQ in a ColQ-deﬁcient
muscle cell line or COS-7 cells, we report that ColQ
clusterizes through a more complex mechanism. This
process requires two heparin-binding sites contained in the
A
 
collagen domain as well as the COOH terminus of ColQ.
Cross-linking and immunoprecipitation experiments in
 
Torpedo
 
 postsynaptic membranes together with transfection
experiments with muscle-speciﬁc kinase (MuSK) constructs
in MuSK-deﬁcient myotubes or COS-7 cells provide the
ﬁrst evidence that ColQ binds MuSK. Together, our data
suggest that a ternary complex containing ColQ, perlecan,
and MuSK is required for AChE clustering and support the
notion that MuSK dictates AChE synaptic localization at the
neuromuscular junction.
 
Introduction
 
Acetylcholinesterase (AChE; EC 3.1.1.7) terminates neu-
rotransmission by hydrolyzing acetylcholine at cholinergic
synapses. The accumulation of AChE in the synaptic cleft is
a prerequisite for a tight control in time and space of the
cholinergic neurotransmission.
At the vertebrate neuromuscular junction (NMJ), much
of the AChE is a collagen-tailed enzyme also called asym-
metric form (A form; Legay, 2000). This molecular form
corresponds to tetramers of AChE
 
T
 
 subunits associated to a
specific collagen called collagen Q (ColQ; Krejci et al., 1991,
1997). ColQ is a collagen in which the central collagenous
domain is flanked by specific NH
 
2
 
 and COOH terminus
peptides. Trimers of ColQ associate in a triple helix tail.
With increasing levels of AChE
 
T
 
, tetramers of catalytic
subunits fill one, two, or three strands of this collagen tail
and are referred as A
 
4
 
, A
 
8
 
, and A
 
12
 
 according to the number
of catalytic subunits per collagen tail. At the NMJ, most of
the enzyme is present as A
 
12
 
 forms. The association between
tetramers of AChE and ColQ relies on the interaction between
the tryptophan amphiphilic tetramerization domain contained
in the COOH terminus of the AChE
 
T
 
 subunit and a proline-
rich domain (PRAD) contained in the NH
 
2
 
 terminus of
ColQ (Bon et al., 1997; Simon et al., 1998).
Several lines of evidences have progressively focused on
ColQ as being responsible for the accumulation of the
enzyme at the NMJ. Indeed, the enzyme has been shown to
be tightly bound to the synaptic basal lamina and most of
the enzyme can be removed by treatment of the muscle with
collagenase (Hall and Kelly, 1971; McMahan et al., 1978).
More recently, the analysis of ColQ-deficient mutant mice
generated by a disruption of the sequence encoding the
PRAD in the ColQ gene has shown that no clusters of
AChE can be detected at the NMJ (Feng et al., 1999).
Congenital myasthenic syndromes associated with AChE
deficiency all result from recessive mutations in ColQ (Engel
et al., 2003). Therefore, the AChE accumulation in the
synaptic cleft relies entirely on ColQ.
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During formation of the vertebrate NMJ, several mecha-
nisms contribute to the postsynaptic differentiation. They in-
clude preferential expression of a class of genes by synaptic
nuclei, lateral diffusion-trap of receptors in the membrane, or
increased stability of synaptic proteins within clusters. The
heparan sulfate proteoglycan (HSPG) agrin released by the
nerve terminal orchestrates the maintenance of most of these
processes. The role of agrin has mainly been dissected
through the accumulation of acetylcholine receptors (AChRs).
In brief, agrin activates a tyrosine kinase receptor called mus-
cle-specific kinase (MuSK), which is specifically concentrated
at the postsynaptic membrane. The activation of MuSK in-
duces a cascade of signal transduction events through rapsyn
leading to the formation of AChR clusters (Sanes and Licht-
man, 2001; Burden, 2002).
Local expression of AChE mRNAs has also been shown to
be responsible for the high expression level of the enzyme at
the NMJ in all types of muscles (Jasmin et al., 1993; Legay et
al., 1995). The pattern of ColQ mRNAs expression is more
complex. Two variants of ColQ called ColQ1 and ColQ1a
that both contain the PRAD are synthesized by the muscle fi-
bers (Krejci et al., 1999). Both ColQ1a and ColQ1 mRNAs
are present all along the muscle fiber in slow muscles whereas
ColQ1a mRNAs are highly accumulated around the synaptic
nuclei in fast muscles. The association of AChE with ColQ
has been shown to generate metabolic stabilization of the en-
zyme (Legay et al., 1999). Given the high concentration of
AChE mRNAs at the synapse, it explains that most of the
collagen present at the synapse is saturated with tetramers of
AChE (A
 
12
 
 forms). Once secreted, A forms interact with
HSPGs in the ECM. Indeed, the enzyme is partly solubilized
by heparin and binding of purified exogenous A
 
12
 
 on sections
of NMJ is blocked by heparin (Brandan et al., 1985; Ro-
tundo et al., 1997). The interaction between ColQ and
HSPGs is only mediated by two clusters of basic residues lo-
cated in the collagen domain (Deprez and Inestrosa, 1995;
Deprez et al., 2003). Perlecan, a major HSPG at the NMJ,
colocalizes with AChE in clusters and binds only to A forms
of AChE suggesting that it participates in ColQ clustering
(Peng et al., 1999). This role of perlecan is further supported
by the analysis of perlecan-null mice in which AChE is unde-
tectable in the NMJ (Arikawa-Hirasawa et al., 2002). In turn,
perlecan binds dystroglycan, a transmembrane protein of the
sarcolemma concentrated at the NMJ (Jacobson et al., 2001).
Therefore, AChE is anchored in the synaptic basal lamina
through the scaffold ColQ–perlecan-dystroglycan. It remains
that heparin or high salt containing buffers only extract newly
formed collagen-tailed AChE (Rossi and Rotundo, 1996).
These results suggested that an other component but HSPG
is stabilizing the hetero-oligomer in the synaptic basal lamina.
Several mutations in the ColQ COOH terminus domain
have been shown to hinder the accumulation of AChE at the
synapse and lead to a myasthenic syndrome associated with
AChE deficiency (Donger et al., 1998; Ohno et al., 1998,
2000). These mutations do not impede the formation of the
triple helix of collagen nor the association of ColQ with
AChE. Furthermore, the deletion of the ColQ COOH ter-
minus domain does not affect the relative affinity of this
mutant protein for heparin and this domain does not inter-
act with heparin (Deprez et al., 2003). These observations
prompted us to hypothesize that beside the interaction with
perlecan, other molecular interactions through the COOH
terminus domain of ColQ may be involved in the accumula-
tion of AChE. Here, we have analyzed the respective roles
of each of the two heparin-binding sites (HBS) which are
known to have different biochemical properties and the
COOH terminus domain in ColQ clustering. We also have
searched for the molecular partner interacting with ColQ
COOH terminus. First, we demonstrate that both the HBS
and the COOH terminus domain of ColQ are involved in
the accumulation of the enzyme in clusters. Second, we show
that ColQ binds MuSK through its COOH terminus.
 
Results
 
Expression of AChE and ColQ in muscle cells
 
We first asked whether the expression of AChE and the two
variants of ColQ, ColQ1, and ColQ1a is regulated during
muscle differentiation. For this purpose, we used time-lapse
RT-PCR to quantify the levels of the specific mRNAs in
myoblasts and myotubes (MTs) in culture. To test whether
the absence of ColQ influences AChE gene expression dur-
ing differentiation, the quantification was done on RNAs
extracted from a wild-type (wt) and from a ColQ-deficient
myogenic cell line that we have generated. Data show that
AChE and ColQ1 mRNAs were up-regulated after fusion of
myoblasts by 130- and 20-fold, respectively, in wt muscle
cells (Fig. 1 A). Thus, the induction of ColQ1 variant upon
Figure 1. Expression of AChE and 
ColQ in mouse wt and ColQ-deficient 
myogenic cells in culture. (A) AChET, 
ColQ1, and ColQ1a mRNAs levels were 
quantified by real-time RT-PCR ( SEM) 
in wt myoblasts and MTs. AChET mRNAs 
levels were increased by 130-fold average 
and ColQ1 mRNAs levels by 20-fold 
average after differentiation into MTs. 
ColQ1a transcripts were only detectable 
in MTs. Note that the bars do not allow 
direct comparison between the different 
transcripts. (B) Cultures were stained 
with either  -bungarotoxin (a and d,  BTX) or the A63 polyclonal rat anti-AChE antibody (b, c, e, and f). Wt and ColQ-deficient MTs formed 
AChR clusters (a and d). AChE clusters did not form in noncontracting MTs (b, ncMT) and were only revealed in contracting MTs (c, cMT). No 
AChE clusters were detected in ColQ-deficient contracting MTs (e). Transfection of ColQ-deficient MTs with rat ColQ1a restores the ability of 
these cells to form AChE clusters in contracting MTs (f). Bar, 20  m. 
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differentiation was much lower than the one observed for
AChE in these muscle cells. The ColQ1a variant was ex-
pressed in wt MTs but could not be detected in wt myoblasts
(Fig. 1 A). In ColQ-deficient muscle cells, AChE mRNAs
were increased by 180-fold in a range nonsignificantly differ-
ent from that observed in wt myogenic cells (unpublished
data). This result suggests that the absence of ColQ in ColQ-
deficient cells does not modify the expression level of AChE
mRNAs. None of the two ColQ variants were detected in
ColQ-deficient muscle cells (unpublished data).
 
Expression of exogenous ColQ in ColQ-deficient cell 
lines restores clusters of AChE
 
Soon after fusion of the MTs, spontaneous AChR clusters
were detected on wt and ColQ
 
 
 
/
 
 
 
 MTs (Fig. 1 B, a and d).
However, AChE aggregates did not form in wt MTs until
muscle cell contraction occurred a week average after fusion
(Fig. 1 B, b and c). This result can be correlated with a dra-
matic increase in AChE and ColQ mRNAs expression (un-
published data) detected concomitantly with muscle cell con-
traction or a process of late differentiation. AChE aggregates
were not present at the surface of ColQ
 
 
 
/
 
 
 
 MTs even when
these MTs were contracting (Fig. 1 B, e). Because the ColQ1a
variant seems to be mostly expressed at the synapse and is only
present in differentiated muscle cells, we transfected ColQ-
deficient myoblasts at confluence with ColQ1a and induced
fusion of the myoblasts the next day. AChE aggregates were
observed in approximately half of the contracting muscle cells
(Fig. 1 B, f). This result indicates (a) that the presence of
ColQ is an absolute prerequisite for the formation of AChE
Figure 2. Distinct sites of ColQ are necessary for the formation of AChE clusters. (A) Analysis of AChE molecular forms secreted from the 
ColQ-deficient myogenic cells transfected with AChET or cotransfected with AChET and wt ColQ or ColQ mutants. Sedimentation profiles of 
the molecular forms are shown in black lines. Asterisk indicates the position of A12 forms in the sedimentation profiles. Co-transfected cells 
were also treated for 24 h by heparin. Sedimentation profiles of the molecular forms secreted after heparin treatment are shown in gray lines. 
A schematic representation of AChE A forms and ColQ mutant constructs used in this work are shown on the left side of the gradients. Catalytic 
subunits (ovoids) are associated to a triple helix of ColQ. This last protein contains a collagen domain (186–285 aa) flanked by a NH2-terminal 
peptide (1–186 aa) and a COOH-terminal peptide (285–450 aa). The two HBS (N
  and C
 ) contained in the collagen domain are indicated 
as gray boxes. In mutant construct N
 /C
 , RK (121–122 aa) is mutated to DP. In mutant construct N
 /C
 , KR (226–227 aa) is mutated to DP. 
In construct N
 /C
 , both sites are mutated. In mutant  Col, amino acids 105–276 were deleted. In mutant  Ct, amino acids 362–450 were 
deleted. The rat Y431S construct reproduces the missense mutation detected in the human ColQ COOH terminus domain. As shown, none of 
the mutations prevented the formation and secretion of AChE A forms. (B) Cells were labeled with antibodies to AChE. Wt myogenic cells 
( / ) formed AChE clusters (a), whereas no AChE clusters were detected in myogenic cells derived from ColQ-deficient mice ( / ; b). ColQ 
transfected in ColQ-deficient muscle cells restored the formation of AChE clusters (c), but no AChE clusters were detected when these cells 
were transfected with either the N
 /C
  construct (d), the N
 /C
  construct (e), the  Col construct (f), the  Ct construct (g), or the Y431S 
construct (h). 
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spontaneous aggregates; (b) that ColQ is able to associate with
endogenous AChE; and (c) that ColQ can restore the ability
of ColQ deficient cells to produce AChE clusters. Finally,
AChR aggregates form independently from those of AChE.
 
The two HBS and the COOH terminus of ColQ are 
necessary for the formation of ColQ clusters
 
To determine the relative functions of the two HBS and the
COOH terminus domain of ColQ in the formation of ColQ
clusters, we transfected ColQ deficient muscle cells with a se-
ries of constructs in which one of the two HBS located in
N
 
 
 
 (N
 
 
 
/C
 
 
 
) or COOH terminus (N
 
 
 
/C
 
 
 
) or both
HBS (N
 
 
 
/C
 
 
 
) within the collagen domain or the main re-
gion of the collagen domain (
 
 
 
Col) or the 88 aa of the
COOH terminus domain of ColQ (
 
 
 
Ct) were mutated or
deleted. All these mutants are described in a previous article
(Deprez et al., 2003). We also generated a rat mutated ColQ
cDNA (Y431S) that reproduced the human point mutation
Y431S in the COOH terminus domain described previously
(Donger et al., 1998). The six mutants used in this work are
schematically represented in Fig. 2 A. To ascertain that these
ColQ mutants were expressed and secreted by ColQ-defi-
cient myogenic cells, we cotransfected these cells with wt or
mutant ColQ and AChE. We then analyzed the AChE mo-
lecular forms secreted in the medium by the sucrose gradient
technique. Because Rossi and Rotundo (1996) showed that
heparin solubilizes newly synthetized A forms, we also ana-
lyzed the AChE molecular forms in the medium after treat-
ment of the cells with heparin. As shown on Fig. 2 A, all
these mutants were expressed and were able to associate with
AChE to form hetero-oligomers that were secreted in the me-
dium. Note that the 
 
 
 
Col mutant presented higher sedimen-
tation coefficients consistent with a decrease asymmetry of
the molecules due to a shortened collagen tail.
As shown on Fig. 2 B, wt MTs formed AChE clusters (a)
whereas no AChE clusters could be detected in ColQ defi-
cient MTs (b). Transient transfections of MTs with wt
ColQ1a restored AChE clusters (c) but neither the N
 
 
 
/C
 
 
 
mutant (d), the N
 
 
 
/C
 
 
 
 mutant (e), the N
 
 
 
/C
 
 
 
 mutant
(unpublished data), the 
 
 
 
Col mutant (f), the 
 
 
 
Ct mutant
(g), nor the Y431S mutant (h) was able to restore AChE
clusters. Thus, because all the mutants can be targeted to the
cell surface, we can conclude that spontaneous AChE clus-
tering requires the presence of each of the two HBS as well
as the COOH terminus of ColQ. AChE clusters were still
detected 2–3 wk after ColQ transfection. This could be
linked to the presence of high level of ColQ 10 d after trans-
fection (not depicted) and the stability of the A forms in the
ECM. Alternatively, ColQ expression in some MTs days af-
ter transfection could result from spontaneous integration
events of ColQ cDNA in the genome.
 
The collagenic tail of AChE is linked to MuSK 
in 
 
Torpedo
 
 postsynaptic membrane
 
To identify MuSK partners in 
 
Torpedo
 
 electrocyte in situ,
we have performed chemical cross-linking experiments in
postsynaptic membrane purified from 
 
Torpedo
 
 electric tissue
(Strochlic et al., 2001). Several cross-linked products con-
taining MuSK were identified using antibodies to MuSK by
Western blotting. Among them, two major cross-linked
products of 125 and 140 kD were detected in addition to
uncross-linked MuSK (97 kD; Fig. 3 A). In the absence of
cross-link, immunopurification experiments revealed a 40-
kD polypeptide that copurified with MuSK (Fig. 3 B). The
140-kD cross-linked product as well as the 40-kD polypep-
tide were analyzed by matrix-assisted laser desorption ioniza-
tion-time of flight (MALDI-TOF) mass spectrometry after
tryptic digestion as described previously (Strochlic et al.,
2001; Fig. 3 C). In the 140-kD cross-linked product, a se-
quence coverage of 6% was obtained with rat MuSK with a
probability score of 10
 
 
 
4
 
. A manual comparison between the
peptides from 
 
Torpedo
 
 and mammalian MuSK led to a
higher coverage between the two sequences (13%), coherent
with the overall 70% amino acid identity between 
 
Torpedo
 
and rat MuSK sequences. In addition to MuSK, MALDI-
TOF mass spectrometry analysis revealed the presence of
ColQ with a coverage of 14%, and an estimated Z score
Figure 3. MALDI-TOF mass spectrometry analysis of MuSK 
complex isolated from Torpedo AChR-rich membranes. (A) Cross-
linking experiment showing a major 140-kD MuSK cross-linked 
product in Torpedo AChR-rich membranes. After separation on 
SDS-PAGE, MuSK (97 kD) from control membranes (left lane) and 
from cross-linked membranes (right lane,  SMPB) were revealed by 
Western-blotting using anti-MuSK antibodies (Abs 2847). (B) Immuno-
precipitation experiments performed on Triton X-100 extracts from 
uncross-linked Torpedo postsynaptic membranes with anti-MuSK 
antibodies. Lane 1 shows the presence of two polypeptides of relative 
MW 97 and 40 kD (silver staining after SDS-PAGE). Lane 2 shows 
Western blots performed with anti-MuSK showing that the 97-kD 
polypeptide corresponds to MuSK. (C) MALDI-TOF mass spectrometry 
analysis of the 140-kD cross-link product and the 40-kD polypeptide. 
Coverage maps are shown. Coverages of 6% with rat MuSK (top) 
and of 14% with rat AChE-associated collagen (ColQ) were obtained 
from the 140-kD cross-link product. On the 19 experimental tryptic 
peptides identified, seven matched with rat ColQ (182-190, 282-292, 
158-169, 170-181, 155-169, 158-175, and 314-332). The matched 
peptides represent 79/458 residues of ColQ (14%). For the 40-kD 
polypeptide, a coverage of 20% was found with rat AChE-associated 
collagen. On the 15 experimental tryptic peptides identified, seven 
matched with rat ColQ (185-196, 200-211, 188-199, 155-169, 
314-332, 197-217, and 238-261). The matched peptides represent 
106/458 residues of ColQ (20%). 
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equals 1.95. MALDI-TOF mass spectrometry analysis of the
40-kD polypeptide revealed a coverage of 20% with ColQ,
and an estimated Z score equals 1.67. These coverages were
in agreement with the extensive sequence homology be-
tween the primary structures of collagenic tails from 
 
Torpedo
 
and mammals (Krejci et al., 1991, 1997). Moreover, im-
munoprecipitation experiments performed in postsynaptic
membranes from 
 
Torpedo
 
 electric tissue with anti-MuSK an-
tibodies revealed that the catalytic subunit of AChE was also
present in the MuSK complex (unpublished data). To-
gether, our data indicate that MuSK is a membrane receptor
for the collagenic tail of AChE. Therefore, we hypothetized
that MuSK participates in AChE clustering on cell surface.
 
MuSK and ColQ form a complex in transfected 
COS-7 cells
 
COS-7 cells do not produce ColQ or MuSK. We first
tested whether MuSK influences the cell surface expres-
sion of ColQ. Because most of ColQ-GFP appears in intra-
cellular compartments (see also infra in Fig. 5), we specif-
ically visualized extracellular ColQ. Unpermeabilized COS-7
cells transfected with rat cDNA encoding ColQ-GFP were
immunolabeled with anti-GFP antibodies revealed with
Cy3-conjugated antibodies (red fluorescence). In these con-
ditions, the red fluorescence reveals the presence of ColQ
exposed at the cell surface (Fig. 4 A). In COS-7 cells trans-
fected with wt ColQ-GFP alone, only a limited number of
cells expressing ColQ-GFP intracellularly also expressed it
at the cell surface (
 
 
 
10%, Fig. 4, A and B). In contrast,
when cells were cotransfected with MuSK-HA and wt
ColQ-GFP, 
 
 
 
50% of the ColQ-GFP–positive cells
expressed ColQ clusters at the cell surface (Fig. 4, A and B).
It should be noted that ColQ clusters per cell were also
increased in the presence of MuSK (unpublished data).
In contrast, the 
 
 
 
Col-GFP and 
 
 
 
Ct-GFP mutants were
poorly accumulated at the cell surface, as shown by the
lower percentage of cells exhibiting clusters in the presence
of MuSK (Fig. 4 B). To further investigate the participation
of MuSK in the surface localization of ColQ, we studied
the co-distribution of the two molecules using double fluo-
rescence experiments in which MuSK-HA was revealed
with Cy3-conjugated anti-HA antibodies and ColQ-GFP
with FITC-conjugated anti-GFP antibodies to enhance the
detection of ColQ-GFP in unpermeabilized cells. Fig. 4
C shows that the majority of ColQ co-distributed with
MuSK-HA within clusters at the cell surface. Thus, ColQ is
retained more efficiently at the cell surface in the presence
of MuSK and this property requires the collagen and the
COOH terminus domains of ColQ.
To define which domain of ColQ is involved in the inter-
action with MuSK, we performed immunoprecipitation ex-
periments with anti-MuSK antibodies (cyt-MuSK) 24 h after
transient cotransfection of COS-7 cells. COS cells were
transfected with cDNAs encoding MuSK-myc and either wt
ColQ-GFP or several deleted or mutated forms of ColQ, i.e.,
 
 
 
Ct-GFP, 
 
 
 
Col-GFP, or Y431S-GFP. As revealed by West-
ern blotting, MuSK-myc and wt ColQ-GFP were detected in
immunoprecipitates with myc and GFP antibodies, respec-
Figure 4. ColQ-GFP and MuSK-HA 
co-aggregate at the cell surface in trans-
fected COS-7 cells. (A) Cell surface 
expression in COS-7 cells transfected 
with cDNAs encoding wt ColQ-GFP 
alone ( MuSK) or cotransfected with 
cDNAs encoding ColQ-GFP and MuSK-
HA ( MuSK) was monitored by indirect 
immunofluorescence performed on 
unpermeabilized cells. Cell surface 
detection of ColQ expression was 
achieved using an additional anti-GFP 
antibody revealed with CY3-conjugated 
antibody. Then, the cell surface labeling 
appeared in red whereas intracellular 
ColQ-GFP was in green. In the absence 
of MuSK, only a few cells expressing 
ColQ-GFP intracellularly exhibited 
surface labeling, usually in clusters 
(B,  10%). In contrast,  50% of ColQ-
GFP–positive cells expressed numerous 
surface clusters of ColQ-GFP in presence 
of MuSK. (B) Quantification of the 
immunolocalization data for wt ColQ 
and ColQ mutants. Ordinate indicates 
the percentage of cells in which surface 
clusters of wt ColQ,  Col, and  Ct were 
detected (n   4). Asterisk indicates 
statistical significance (P   0.05) for the 
data shown in A. No significant increases in cells expressing  Col-GFP or  Ct-GFP after MuSK transfection were observed. Means   SEM are 
shown. (C) Wt ColQ-GFP and MuSK-HA co-distributed in aggregates at the cell surface as revealed by indirect immunofluorescence experiments 
performed on unpermeabilized cells. Enhancement of ColQ labeling at the cell surface was achieved using an additional anti-GFP antibody 
revealed with a FITC-conjugated goat anti mouse antibody. An anti-HA antibody was used to reveal MuSK followed by Cy3-conjugated goat 
anti–rabbit antibody. Note that colors are inverted for ColQ detection at the cell surface in A and C. Bars, 10  m. 
510 The Journal of Cell Biology 
 
|
 
 
 
Volume 165, Number 4, 2004
 
tively (Fig. 5 A, lanes 1 and 2). MuSK-myc and ColQ-GFP
deleted from its collagenic domain ( Col-GFP) also coim-
munoprecipitated (Fig. 5 A, lanes 5 and 6). Conversely,  Ct-
GFP or Y431S-GFP was not recovered in immunoprecipi-
tates (Fig. 5 A, lanes 3 and 4, and lanes 7 and 8, respectively).
In these experiments, we have verified that both MuSK-myc
(Fig. 5 B, WB anti-MuSK) and ColQ-GFP mutants were ex-
pressed in transfected cells (Fig. 5 B, WB anti-GFP). In par-
ticular,  Ct-GFP and  Col-GFP constructs were expressed
at a high level strengthening the results of the immunopre-
cipitation experiments (Fig. 5 A, lanes 3 and 4, and lanes 5
and 6, respectively). These data demonstrate that the noncol-
lagenous COOH-terminal domain of ColQ contains a bind-
ing site for MuSK whereas the collagen domain of ColQ is
not involved in MuSK interaction. Large intracellular pools
of transfected MuSK-HA and ColQ-GFP were detected
when cells were permeabilized before immunolabeling. Both
ColQ-GFP and MuSK-HA co-distributed within intracellu-
lar compartments (Fig. 5 C), likely of the exocytic pathway,
as shown by the co-labeling of these compartments by the
lectin WGA-RITC, a marker of Golgi compartment (Fig. 5
D). Thus, the immunoprecipitation experiments shown in
Fig. 5 A partly reflect intracellular association.
ColQ-GFP, MuSK-HA, and perlecan co-distribute 
in transfected COS cells
We observed that the truncated  Col mutant lacking the col-
lagen domain containing the two HBS, though coimmu-
noprecipitating with MuSK by its COOH-terminal domain,
was less efficiently accumulated at the cell surface of MuSK
cotransfected COS-7 cells compared with wt ColQ (Fig. 4 B).
Similarly, the  Ct mutant lacking the COOH-terminal do-
main involved in the interaction with MuSK was also less effi-
ciently accumulated in the MuSK cotransfected cells (Fig. 4
B). Thus, the collagen and the COOH-terminal domains are
both required for cell surface localization of ColQ. To deter-
Figure 5. ColQ-GFP and MuSK-myc coimmuno-
precipitate in COS cells. (A) Coimmunoprecipitation 
experiments were performed after cotransfection of 
COS-7 cells with constructs encoding wt ColQ-
GFP or several deleted forms of ColQ-GFP ( Col 
and  Ct) or of a point mutation in ColQ COOH-
terminal domain (Y431S) together with MuSK-myc. 
Immunoprecipitates were done with anti-MuSK 
antibodies and revealed by Western blotting using 
anti-myc and anti-GFP antibodies. Lanes 1, 3, 5, and 
7 indicate anti-myc; lanes 2, 4, 6, and 8 indicate 
anti-GFP. Only wt ColQ-GFP (80 kD; lane 2, asterisk) 
and the truncated  Col-GFP form (60 kD; lane 6, 
asterisk) coimmunoprecipitated with MuSK. (B) 
The levels of expression of MuSK (WB anti-MuSK) 
and the various forms of ColQ (WB anti-GFP) were 
shown by Western blotting performed on cell lysates 
from the same experiment as shown in A. Note that 
 Ct and  Col are particularly highly expressed. 
Asterisks indicate the position of the main ColQ 
polypeptides (apparent MW 79 kD, 72 kD, 58 kD, 
and 78 kD for ColQ wt,  Ct,  Col, and Y431S, 
respectively). (C) Colocalization of wt ColQ-GFP 
and MuSK-HA within intracellular compartments 
of transfected COS-7 cells. (D) ColQ-GFP labeling 
coincided to a large extent with the labeling of
N-acetylglucosamine revealed by the lectin WGA, 
a marker of the Golgi compartment. Bar, 10  m.
Figure 6. ColQ-GFP, MuSK, and perlecan co-
distribute in transfected COS-7 cells. COS-7 cells 
were cotransfected with cDNA encoding ColQ-
GFP and MuSK-HA, and visualized by triple indirect 
immunofluorescence performed on unpermeabilized 
cells. ColQ-GFP labeling exposed at the cell surface 
was amplified using an additional anti-GFP antibody 
revealed with a FITC-conjugated goat anti–mouse 
antibody (see Materials and methods). Triple labeling 
imaging showing that ColQ-GFP (A), MuSK-HA (B), 
and perlecan (Cy5 fluorescence in false blue color 
in C) colocalized within clusters at the cell surface. 
The white color in the overlay (D) corresponded to 
the superimposition of the three proteins: green, 
ColQ-GFP; red, MuSK-HA; blue, perlecan (arrows). 
Details of the cell surface labeling of these three 
proteins are shown in E. Bars: (A) 10  m; (E) 3  m.MuSK binds AChE at the neuromuscular junction | Cartaud et al. 511
mine whether the aggregates containing ColQ and MuSK also
contained perlecan, we looked for the presence of perlecan in
these aggregates in triple immunofluorescence experiments.
We first verified that cultured COS-7 cells express perlecan at
the cell surface (unpublished data). Triple labeling experi-
ments were performed in COS-7 cells doubly transfected with
ColQ-GFP and MuSK-HA. Strikingly, ColQ-GFP clusters
mostly co-distributed with MuSK-HA and perlecan (Fig. 6,
A–E). In rare occurrence, ColQ-GFP clusters not associated
with MuSK/perlecan were observed. Together, with the previ-
ous data which emphasize the requirement of the two HBS
and COOH-terminal domain of ColQ in the anchoring of
AChE at the cell surface, these experiment suggest that a ter-
nary complex comprising ColQ, MuSK, and perlecan partici-
pates to the mechanism of AChE accumulation.
MuSK expression restores ColQ clusters 
in MuSK-deficient MTs
Because no cluster of AChE are detected in MuSK deficient
MTs (DeChiara et al., 1996), we wondered whether these
cells produce A forms. As shown by sedimentation analysis,
they do express these molecular forms (Fig. 7 A). No AChE
clusters could be seen in MuSK-deficient MTs (Fig. 7 B, a)
but when these cells were transfected with a rat MuSK
cDNA, MuSK expression rescued the ability of these MTs
to form spontaneous AChE clusters (Fig. 7 B, b). When
MuSK-HA and ColQ-GFP were cotransfected in MuSK-
deficient MTs, most of these two proteins were shown to
colocalize (Fig. 7 B, c–e).
Discussion
The localization of AChE at synaptic sites in muscle relies
on the presence of a structural subunit, ColQ. Various ob-
servations prompted us to seek another direct partner in ad-
dition to perlecan in the clustering of AChE at the NMJ.
Here, we report that the hetero-oligomer AChE-ColQ is ac-
cumulated in clusters through a complex mechanism that
involves three sites, the two HBS contained in the collagen
domain and the COOH terminus of ColQ. We demon-
strate that none of the three sites are dispensable for accu-
mulating ColQ at the cell surface in MTs or COS-7 cells.
We provide the first evidence that ColQ binds MuSK
through its COOH-terminal domain.
AChE clusters form with muscle cell late differentiation
Previous works have shown that a number of synaptic pro-
teins including AChE, are up-regulated upon MT formation
(Chakkalakal and Jasmin, 2003). This process also applies to
ColQ. In our mouse muscle cell cultures, AChE clusters ap-
pear at the time of muscle contraction. This is consistent
with the absence of AChE clusters in C2C12 mouse muscle
cell line that does not spontaneously contract (unpublished
data). It has been reported that spontaneous contraction of
rat muscle cells grown in neuron-free primary cultures stimu-
lates the synthesis of AChE subunits, a process that can be
mimicked by the addition of calcium in the absence of con-
traction (Rubin, 1985). Because calcium has been shown to
stabilize AChE mRNAs (Luo et al., 1994), we may then hy-
pothesize that spontaneous muscle contraction induces a
large increase in intracellular calcium concentration which, in
turn, leads to an increase in the number of AChE subunits
synthesized. As a consequence, AChE subunits would fill the
three strands of ColQ and the saturated hetero-oligomers
would then become detectable within clusters. Furthermore,
contraction correlates with a large increase in ColQ mRNAs
levels, a process that could also induce the production of
AChE-collagen–tailed forms. However, we cannot exclude
that the formation of clusters are generated from a late differ-
entiation process occurring with muscle contraction.
Distinct sites located within ColQ are necessary for the 
formation of AChE clusters
Previous observations from ColQ-deficient mouse have
shown in vivo that the formation of AChE synaptic clusters
relies on the presence of ColQ (Feng et al., 1999). ColQ-
deficient myogenic cells are devoided of AChE clusters, and
the transfection of ColQ in these cells restores the presence
Figure 7. MuSK restores the formation of AChE clusters in MuSK-deficient MTs. (A) Sedimentation analysis of the molecular forms produced 
by MuSK-deficient cells revealed that these cells produced A12 forms indicated by the asterisk in the sedimentation profile. (B) MTs in culture 
were labeled with antibodies to either AChE (a and b) or to MuSK-HA or to ColQ-GFP (c and d). No AChE (a) clusters were detected in MuSK-
deficient MTs. AChE clusters were restored when MuSK-deficient MTs were transfected with rat MuSK (b). Clusters of MuSK-HA (c) and 
ColQ-GFP (d) colocalized in MuSK-deficient cells cotransfected with MuSK-HA and ColQ-GFP as shown on the overlay picture (e). Arrows 
show colocalizations of ColQ-GFP and MuSK-HA. Bar, 20  m.512 The Journal of Cell Biology | Volume 165, Number 4, 2004
of clusters confirming the in vivo results. AChE accumula-
tion in the basal lamina does require ColQ.
Using a series of constructs in which each one of the two
HBS or the COOH terminus domain of ColQ was mu-
tated, we demonstrated that AChE accumulation requires
the presence of the three sites in MTs and in COS-7 cells.
Previous data have demonstrated that the affinity of ColQ
for heparin resides exclusively in two HBS contained in the
collagen domain and that these two sites have different bio-
chemical properties (Deprez et al., 2003). The biochemical
specificity of these sites is strengthened by our data showing
that the two HBS are not redundant in clustering ColQ. Be-
cause the ColQ COOH terminus domain has no affinity for
heparin, it excludes the possibility that this domain interacts
with HSPGs.
Our results explain observations made in patients bearing
mutations in the COOH terminus domain of ColQ associ-
ated with a congenital end plate AChE deficiency (Ohno et
al., 2000). For most of these mutations, tetramers of cata-
lytic subunits and ColQ associate but A forms do not accu-
mulate in the NMJ. In the case of the point mutation Y431S
that we have reproduced in the rat ColQ cDNA for this
work, trace amounts of AChE are detected at the end plate
of intercostal muscles in patients although normal levels of A
forms were produced (Donger et al., 1998). Thus, this mu-
tation prevents or severely hinders the accumulation of
AChE into the synaptic basal lamina. The present data show
that this single point mutation in the COOH terminus do-
main of ColQ is critical for the synaptic accumulation of
AChE.
ColQ binds MuSK trough its COOH terminus
Several mouse mutants are characterized by an absence or a
reduction in the number of AChE clusters at the synapse.
These mutants can be classified in three groups: (1) mutants
of the basal lamina proteins such as perlecan; (2) mutants
of intrinsic membrane proteins such as dystroglycan and
MuSK; and (3) mutants of extrinsic or cytoskeletal proteins
such as rapsyn and  -syntrophin (for review see Sanes and
Lichtman, 2001). For most of these mutants, the absence of
AChE clusters can be explained by a perturbation of the
ColQ–perlecan-DG scaffold. The perturbation results either
from the absence of one of the ColQ partners in the scaffold
or from the absence of a key component involved in the as-
sembly of the scaffold, i.e., MuSK. Alternatively, ColQ
COOH terminus could directly bind to MuSK.
Here, we provide compelling biochemical and cytological
evidences that ColQ binds MuSK. (a) Cross-linking experi-
ments argue in favor of a direct link between MuSK and
ColQ. (b) Mutants of ColQ bearing a deletion or the point
mutation Y431S in the COOH terminus domain are ex-
pressed but cannot be immunoprecipitated together with
MuSK from transfected COS-7 cells. Thus, the AChE defi-
ciency observed in patients bearing the Y431S mutation can
now be explained by the lack of interaction between ColQ
and MuSK. (c) AChE clusters do not form in MuSK-defi-
cient cells although both AChE and ColQ are expressed in
these cells. (d) MuSK restores the presence of AChE clusters
in MuSK-deficient cells. (e) ColQ colocalizes with MuSK in
clusters. Although perlecan has been suggested to be the
unique acceptor molecule for AChE-ColQ at the NMJ
(Arikawa-Hirasawa et al., 2002), our observations show that
MuSK also binds ColQ and is necessary for AChE-ColQ ac-
cumulation. Together, the present data provide a simple
mechanism for the accumulation of collagen-tailed forms of
AChE at synaptic sites. Whereas perlecan is rather widely
distributed along the entire muscle basal lamina, MuSK is
strictly accumulated at the synapse. Therefore, the collagen-
tailed forms of AChE can only be accumulated at the syn-
apse where its two binding partners, perlecan and MuSK co-
exist. This is corroborated by previous observations showing
that MuSK injected ectopically in soleus muscle induces the
formation of AChE clusters (Sander et al., 2001). Indeed, in
extrasynaptic domains of this muscle, perlecan, ColQ, and
AChE are present and the injection of MuSK complements
the set of molecules necessary for AChE cluster formation.
At the NMJ, MuSK is mostly observed at the crests of the
postsynaptic membrane folds (Trinidad et al., 2000). This
localization does not completely overlap AChE distribution
at the synapse, which is distributed at the crests and the
depths of the folds (Anglister et al., 1998; unpublished
data). One explanation would be that MuSK is also present
in the depths of the folds but at a lower level compared with
the top of the folds, still compatible with the formation of
the complex. An alternative hypothesis is that the COOH
terminus domain of ColQ could bind another component
present in the depths of the folds.
In this work, we show that ColQ, in addition to nerve-
derived agrin, binds MuSK. In ColQ-deficient MTs in culture,
the number of AChR aggregates increased when agrin was
applied to the culture (unpublished data). Because ColQ is
dispensable for agrin-induced AChR clustering, it is not the
coreceptor for agrin. However, we cannot exclude that ColQ
could modulate the effect of agrin on MuSK. Accordingly,
Hopf and Hoch (1997) have suggested that in addition to
agrin, a component sensitive to heparin binds MuSK and
modulates its activity.
Clusters of AChE and AChR form independently
An interesting conclusion drawn from the present observa-
tions is that the formation of AChR and AChE clusters both
relies on MuSK but through independent mechanisms.
Whereas clusters of ACh receptors form in response to a
transduction pathway induced by agrin-activated MuSK,
AChE clusters form by structural interaction between ColQ
and MuSK. Whether the interaction of ColQ with MuSK is
strictly structural or could also activate a downstream path-
way remains an open question.
MuSK: a central piece in the assembly of AChE clusters 
at the NMJ
In conclusion, the data reported here have focused on two
classes of binding sites in ColQ which are required in the
mechanism of AChE accumulation, pointing to the direct
interaction of ColQ with perlecan and MuSK. Indeed, the
three proteins form co-clusters in transfected COS cells. The
present data suggest that a ternary complex involving MuSK
and perlecan is responsible for the anchoring of AChE at the
NMJ. As presented in our model (Fig. 8), a dual mechanism
involving two different classes of binding sites is required forMuSK binds AChE at the neuromuscular junction | Cartaud et al. 513
accumulating the enzyme in the synaptic cleft: one through
the postsynaptic receptor MuSK conferring synaptic local-
ization, and another through interactions with the HSPG,
perlecan. We can hypothesize that these multiple interac-
tions on ColQ are necessary for anchoring such a large mol-
ecule in the synaptic cleft.
Materials and methods
Antibodies and reagents
Polyclonal 2847 anti-Torpedo MuSK antibodies were a gift from S. Burden
(Skirball Institute of Biomolecular Medicine, New York, NY; Watty et al.,
2000). Polyclonal MuSK antibodies raised against the cytoplasmic domain
of rat MuSK (cyt-MuSK) were a gift from W. Hoch (University of Houston,
Houston, TX; Hopf and Hoch, 1998). Rabbit polyclonal anti-HA, chicken
polyclonal anti-HA, mouse monoclonal anti-Myc, and monoclonal anti-
GFP antibodies were purchased from Santa Cruz Biotechnology, Inc., In-
vitrogen, ICL, and Roche Molecular Biochemicals, respectively. Rabbit
polyclonal antibodies directed against the COOH terminus domain (do-
main V) of perlecan were a gift from R. Timpl (Max-Planck Institute, Mar-
tinsried, Germany). A63 is a polyclonal rat anti-AChE raised in rabbit
(Marsh et al., 1984). Goat CY3-conjugated polyclonal anti–chicken and
donkey CY5-conjugated polyclonal rabbit antibodies were purchased from
Abcam and Jackson ImmunoResearch Laboratories, respectively. RITC-
conjugated WGA was purchased from Sigma-Aldrich.
Constructs
The rat AChET and ColQ1a clones have been described previously (Legay
et al., 1993; Krejci et al., 1999). A GFP tag was introduced 5  from the
PRAD exon in the ColQ-GFP construct. ColQ mutants  Ct,  Col, N /C ,
N /C , and N /C  have been described previously (Deprez et al.,
2003). ColQ Y431S is a ColQ construct in which we have reproduced the
human Y431S mutation by mutagenesis. MuSK cDNA clone, MuSK-HA,
and MuSK-myc constructs were gifts from W. Hoch (Hopf and Hoch,
1997). The tags HA and myc were introduced at the NH2 and COOH ter-
minus, respectively. The MuSK-GFP construct was a gift from V. Witze-
mann (Max-Planck Institute, Martinsried, Germany; Sander et al., 2001).
Real-time RT-PCR assay
Total RNA was isolated using the RNeasy protect mini-kit (QIAGEN). 0.5
 g of purified RNAs were reversed transcribed using 500 ng of oligodT
primers and the superscript II RNaseH kit (Invitrogen). RT reactions were
performed three times on each RNA and the PCR reaction was repeated
three times from each RT. Specific pairs of primers were as follows. F and
R referred to the forward and reverse primers, respectively. Primers for
AChET cDNAs were 5 -GCAATATGTGAGCCTGAACCTG-3  (AChETF) and
5 -TCACAGGTCTGAGCAGCGTTC-3  (AChETR). Primers for ColQ1 and
ColQ1a cDNAs were: 5 -CAACTCTTCTTCTGCTCCATCG-3  (ColQ1F),
5 -CTTTGGTCCTGTCTTGCCAG-3  (ColQ1R), and 5 -ACGGGTCCAT-
CATTCACTCATC-3  (ColQ1aF). The ColQ1aR was identical to ColQ1R.
GADPH cDNAs were used as internal standards. Primers for GAPDH
were: 5 -ATGAATACGGCTACAGCA-3  (GADPHF) and 5 -GCCCCTC-
CGTTATTATGG-3  (GADPHR). Amplifications were performed in a light
cycler (Roche Diagnostics) using the Quantitect SYBR Green PCR kit
(QIAGEN). Denaturation and activation of the Hotstart polymerase were
performed at 94 C for 14 min (1 cycle) followed by 50 cycles of denatur-
ation, hybridization, and extension of 94 C for 10 s, 62 C for 27 s, and
72 C for 13 s. Standard linear curves were generated for each couple of
primers using serial dilutions of the RT reaction. Quantifications were
made from cycle threshold (CT) within these standard curves. Relative ex-
pression levels of AChET, ColQ1, and ColQ1a mRNAs were determined
according to GAPDH levels as an internal control.
Muscle cell cultures, transfections, immunocytochemistry, 
and molecular form analysis
Two muscle cell lines were generated from wt and ColQ
 / : H-2kb-tsA58
week-old mice. These mice bear a temperature-sensitive SV40 T antigene
under the control of an interferon-inducible promoter (Jat et al., 1991).
Limb muscles of the transgenic mice were dissociated and the cell lines
were established according to the protocol described in Herbst and Bur-
den (2000). Myoblast cells were cultured at 33 C in 8.5% CO2 and in DME
supplemented with 2 mM glutamine, 2% penicillin/streptomycin (5,000 U),
and 20 U/ml of  -interferon (Roche Diagnostics). All the culture medium
reagents were purchased from Invitrogen Life Technologies. Cells were dif-
ferentiated into MTs in the same medium without interferon.
For expression assays, cells were cultured on plates coated with Matri-
gel (Becton Dickinson) and were transfected as 80% confluent myoblasts
with ExGen 500 (Euromedex). Cells were induced to fuse one day after
transfection. Using this protocol, 50–70% of the cells expressed the trans-
fected cDNAs.
Immunostaining was performed either 5–7 d after transfection or 15–20 d
after transfection for contracting MTs. MTs were fixed for 10 min in 2%
PFA-phosphate buffer. In some experiments, cells were permeabilized
with 0.5% Triton X-100 for 5 min before proceeding to incubations with
antibodies. Before the reaction with antibodies, non specific binding was
blocked using the block reagent (DakoCytomation) for 10 min. Cells were
first incubated with the primary antibody for 1 h at RT and washed in Gly-
cine-BSA (0.15%:0.15%) buffer and incubated with a fluorochrome-conju-
gated secondary antibody for 30 min. All of the fluorochrome-conjugated
antibodies were purchased from Jackson ImmunoResearch Laboratories
and used at a 150 mM concentration. When double labeling was per-
formed, the two primary antibodies were sequentially used.
AChE was visualized with the polyclonal A63 antibody raised against
rat AChE (Marsh et al., 1984). Proteins tagged with GFP were visualized
using GFP antibodies (1:200; Roche Diagnostics). MuSK tagged with the
HA epitope was revealed with rat monoclonal anti-HA (1:1,000; Roche
Diagnostics). AChRs were visualized with  -bungarotoxin conjugated ei-
ther to Alexa 488 or to rhodamine (Molecular Probes). Micrographs were
taken with a DMR microscope (Leica) equipped with an NA1.4 63  Plan
Apo objective. Images were captured with a Micro MaX cooled CDD cam-
era (Princeton Instruments, Inc.) driven by Meta View Imaging system
(Universal Imaging Corp.). Figures were organized using Adobe Photoshop
v6.0.
Analysis of the molecular forms was done by sucrose density gradient
centrifugation as described previously (Bon et al., 1997). For analysis of the
molecular forms produced by ColQ-deficient cells cotransfected with
AChE and the wt or mutant ColQ constructs, the procedure was the fol-
lowing. Transfected cells were cultured in differentiation medium for
144 h and a first aliquot was taken at that time for sedimentation analysis.
The same transfected cells were then treated with heparin (1 mg/ml in the
culture medium; Sigma-Aldrich) for 24 h and a second aliquot was ana-
lyzed at the end of this treatment.
COS-7 cell culture, transfections, and immunofluorescence
For transfection experiments, COS-7 cells (purchased from American Type
Culture Collection) cultured in DME were grown to 70% confluence on
coverslips and transfected using FuGene 6 (Roche Diagnostics). Immuno-
precipitation and immunofluorescence analyses were performed 48 h
later. For indirect immunofluorescence, cells were rinsed in PBS at 37 C,
blocked in PBS, BSA 1%, goat serum 0.5% for 20 min at RT, and incu-
bated with primary antibodies without permeabilization of the cells to de-
tect cell surface ColQ-GFP or MuSK-HA. For double fluorescence, mono-
clonal anti-GFP antibodies (1:20) and rabbit polyclonal anti-HA (1:500)
used as primary antibodies were revealed with goat FITC-conjugated anti–
Figure 8. Model illustrating the dual mechanism by which the A 
forms of AChE are accumulated at synaptic sites. The two types of 
interactions between (a) the COOH terminus of ColQ and MuSK, 
and (b) the two HBS (gray boxes) in the collagen domain of ColQ and 
perlecan are shown. The interaction of perlecan and dystroglycan 
( DG and  DG) is also represented. This model accounts for the 
accumulation of AChE in the synaptic basal lamina enriched in 
perlecandystroglycan and for its precise localization at postsynaptic 
sites via MuSK.514 The Journal of Cell Biology | Volume 165, Number 4, 2004
mouse antibodies (1:200) or Cy3-conjugated anti–rabbit (1:100), respec-
tively. For triple fluorescence analyses, monoclonal anti-GFP antibodies
(1:20), chicken polyclonal anti-HA (1:100) and rabbit polyclonal antiperle-
can antibodies (1:50) used as primary antibodies were revealed with
goat FITC-conjugated anti–mouse (1:200), Cy3-conjugated anti–chicken
(1:100), and Cy5-conjugated anti–rabbit antibodies (1:200), respectively. In
another series of experiments, to detect intracellular as well as cell surface
labeling, transfected cells were permeabilized with Triton X-100 0.1% af-
ter fixation in 3% PFA and before incubation with either rabbit polyclonal
anti-HA antibodies (1:500), followed by goat Cy3-conjugated anti–rabbit
(1:100) or WGA-RITC (Sigma-Aldrich; 1:400). For double- and triple-fluo-
rescence pictures, controls confirmed that no bleedthrough was detectable
under the conditions used (filter L5 for fluorescein, TX for CY3, or XF 47
for CY5). CY5 fluorescence was artificially colored in blue. Micrographs
were taken as described above. For quantification of cells expressing wt
ColQ or mutants ColQ  Ct-GFP or  Col-GFP at the cell surface, we
counted the number of cells expressing Cy3-labeled ColQ-GFP or  Ct-
GFP or  Col-GFP at the surface versus cells expressing intracellular wt
ColQ-GFP or  Ct-GFP or  Col-GFP. For each experiment  150 GFP-pos-
itive cells were counted using a 40  objective.
Means reported in Fig. 4 were compared by analysis of variance. The
equal variance test is significant with P   0.05. Pair wise multiple compar-
isons were made with t test.
Immunoprecipitation of MuSK-ColQ complexes in COS-7 cells
Culture dishes of 70% confluent COS-7 cells transfected with ColQ-GFP
or mutants  Ct-GFP,  Col-GFP, or Y431S and MuSK-myc were harvested
in a lysis buffer (50 mM Tris, 150 mM NaCl, 2 mM EDTA, 2 mM orthovan-
adate, 1% Triton X-100) and 0.3 mM PMSF (Sigma-Aldrich) and antipro-
teases (1  g/ml leupeptin, 1  g/ml pepstatin, and 1  g/ml aprotinin), pH
7.5, for 30 min at 4 C. Immunoprecipitation were performed on 1 ml of
cell lysates incubated with 3  g of anti–cyt-MuSK antibodies. Immuno-
complexes were precipitated with protein A Sepharose according to the
manufacturer’s instructions (Amersham Biosciences) for 3 h at 4 C. Immu-
noprecipitates were then washed in lysis buffers, resuspended in 1  SDS
sample buffer, resolved by 10% SDS-PAGE, and analyzed by Western
blotting using anti-myc (1:1,000) and anti-GFP (1:200) antibodies. Aliquots
from cell lysates were also used for detection of the levels of expression of
MuSK and ColQ polypeptides by Western blotting.
Cross-linking experiments
Cross-linking experiments in Torpedo AChR-rich membranes (4 mg pro-
teins/ml) were performed according to Burden et al. (1983) using succin-
imidyl 4(p-maleimidophenyl)-butyrate as described in Strochlic et al.
(2001). The detection of MuSK in the cross-link products was subsequently
achieved by Western blotting using anti–Cyt-MuSK (1:200) or 2847 anti-
bodies (1:2,000) after separation of the proteins on 10% SDS-PAGE.
SDS-PAGE and Western blots
Samples were run on 10% SDS-PAGE according to Laemmli (1970) and
electrotransferred to nitrocellulose membranes (Schleicher & Schuell).
Western blots were performed as described previously (Cartaud et al.,
1998) and revealed using ECL (Amersham Biosciences).
Immunopurification of the MuSK complex and MALDI-TOF 
mass spectrometry
Immunoprecipitation of the MuSK complex and MALDI-TOF spectrometry
from fresh Torpedo electrocyte were performed as described in Strochlic et
al. (2001).
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Note added in proof. While this paper was being reviewed, the groups of
Rotundo and Engel also presented evidence that the two heparin-binding
sites and the COOH terminus domain of ColQ are required for AChE accu-
mulation (Kimbell, L.M., K. Ohno, A.G. Engel, and R.L. Rotundo. 2004. J.
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